Paul Ehrlich Institute
|
Paul Ehrlich Institute - Federal Institute for Vaccines and Biomedical Medicines |
|
|---|---|
|
|
| State level | Federation |
| position | Higher federal authority (from November 1, 1972) |
| Supervisory authority | Federal Ministry of Health |
| founding | June 1, 1896 ( Steglitz near Berlin) |
| Headquarters | Long |
| Authority management | Klaus Cichutek , President |
| Servants | 793 |
| Budget volume | EUR 72.96 million (2019) |
| Web presence | www.pei.de |
The Paul Ehrlich Institute ( PEI ) in Langen is the German federal institute for vaccines and biomedical drugs . On July 23, 2009, the new authority name replaced the old name of the Federal Office for Sera and Vaccines . It is a higher federal authority within the portfolio of the Federal Ministry of Health . It was named after its first director, the German physician and Nobel Prize winner Paul Ehrlich . On July 7, 1972, with the law establishing a Federal Office for Sera and Vaccines, it became an independent higher federal authority.
tasks
The Paul Ehrlich Institute is responsible for the approval and state batch release of medical technology devices , vaccines and biomedical drugs and makes a significant contribution to the safety of these drugs. Since August 2004 (12th amendment to the Medicines Act ), the institute has also been responsible for approving clinical studies for the medicinal products it supervises.
Medicines that are evaluated by the Paul Ehrlich Institute include
- Vaccines and sera for humans and animals,
- Allergen preparations ,
- monoclonal antibodies ,
- Medicines made from blood,
- Advanced Therapy Medicines (somatic cell therapeutics, gene therapeutics, tissue engineering products) and
- Tissue preparations.
An important task of the Paul Ehrlich Institute is not only approval but also scientific advice. Research is also one of the institute's central tasks.
In July 2005 the World Health Organization named the institute a WHO collaborating center for the quality assurance of blood products and in-vitro diagnostics . In August 2013 the Paul Ehrlich Institute became WHO collaborating center for the standardization and evaluation of vaccines.
Others
- The institute awards the Paul Ehrlich Medal and the Langen Science Prize to deserving scientists.
- The PEI is a member of the working group of departmental research institutions .
- PEI announcements appear in the Federal Health Gazette, published by Springer Nature .
- Within the institute there are laboratories of the biological protection level BSL-3.
- The PEI operates the German Haemophilia Register (DHR).
Winner of the Paul Ehrlich silver medal
- Dietrich Falke (awarded on April 21, 1995)
Web links
Individual evidence
- ↑ management team. In: pei.de, accessed April 1, 2013.
- ↑ Federal budget. In: Bundeshaushalt.de. Retrieved August 30, 2019 .
- ↑ a b Law on the Federal Institute for Vaccines and Biomedical Medicines. In: gesetze-im-internet.de. Retrieved January 17, 2017 .
- ^ PEI tasks. In: pei.de. Retrieved January 17, 2017 .
- ↑ WHO collaborating center for blood products and in vitro diagnostics. In: pei.de. Retrieved January 17, 2017 .
- ↑ PEI WHO Collaborating Center: Standardization and Evaluation of Vaccines. In: pei.de. Retrieved January 17, 2017 .
- ↑ Long Science Prize. In: pei.de. Retrieved January 17, 2017 .
- ↑ ISSN 1436-9990 .
- ^ German Center for Infection Research. As of July 30, 2014.
Federal Institute for Drugs and Medical Devices (BfArM) | Federal Social Security Office (BAS) | Federal Center for Health Education (BZgA) | The Federal Government Commissioner for Patients and Authorized Care Representatives | Drug Commissioner of the Federal Government | Paul Ehrlich Institute (PEI) - Federal Institute for Vaccines and Biomedical Medicines | Robert Koch Institute (RKI) - Federal Institute for Infectious Diseases and Non-Communicable Diseases
Coordinates: 50 ° 0 ′ 22 ″ N , 8 ° 38 ′ 59 ″ E